These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27865932)

  • 1. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting Immune Efficacy of the Oral Helicobacter pylori Vaccine by HP55/PBCA Nanoparticles against the Gastrointestinal Environment.
    Liu H; Liu W; Tan Z; Zeng Z; Yang H; Luo S; Wang L; Xi T; Xing Y
    Mol Pharm; 2018 Aug; 15(8):3177-3186. PubMed ID: 30011213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
    Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
    Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
    Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
    Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines.
    Luo S; Liu W; Zeng Z; Ye F; Hu C; Xu N; Huang A; Xi T; Xing Y
    Helicobacter; 2018 Dec; 23(6):e12536. PubMed ID: 30247802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Protection Against
    Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
    Front Immunol; 2019; 10():1185. PubMed ID: 31191547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
    Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
    World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Immunization With a M Cell-Targeting Recombinant
    Guo L; Zhang F; Wang S; Li R; Zhang L; Zhang Z; Yin R; Liu H; Liu K
    Front Immunol; 2022; 13():918160. PubMed ID: 35911756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.
    Goto T; Nishizono A; Fujioka T; Ikewaki J; Mifune K; Nasu M
    Infect Immun; 1999 May; 67(5):2531-9. PubMed ID: 10225917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
    Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
    Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice.
    Chen M; Chen J; Liao W; Zhu S; Yu J; Leung WK; Hu P; Sung JJ
    Helicobacter; 2003 Dec; 8(6):613-25. PubMed ID: 14632677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.